Inceptiv is a small device, implanted in the lower torso with leads to the spinal cord, that provides responsive counter-stimulation to relieve chronic pain. The device was approved by the FDA in ...

The global spinal cord stimulators market is on a robust growth trajectory, poised to reach an impressive valuation of USD 5,441.4 million by 2033. Currently valued at USD 2,702.7 million in 2023, the ...

Spinal cord and dorsal root ganglion stimulation are established, safe treatments for chronic pain, but they carry a high explantation risk over a long-term period. The long-term explantation ...

27.5% from Medtronic, 22.5% from Nevro, 11.8% from Abbott, and 1.3% from Saluda. Among 47 patients implanted with Abbott devices, 34% received a system for DRG stimulation. The ean (SD) age at ...

using spinal cord transcutaneous stimulation (scTS). This promising approach to enhance cardiovascular regulation addresses the challenges of unstable blood pressure and the accompanying ...

The Affera mapping and ablation system with the Sphere-9 catheter [Images courtesy of Medtronic] Medtronic (NYSE:MDT) today said it received FDA approval for its Affera mapping and ablation system ...

Spinal meningitis is the inflammation of tissues, called the meninges, that surround and protect the brain and spinal cord. It usually stems from an infection, leading to symptoms such as a stiff neck ...

Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation ...